Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
52
IVPAF Quote, Financials, Valuation and Earnings
Last price:
$8.04
Seasonality move
:
9.96%
Day range:
$7.75 - $7.99
52-week range:
$6.50 - $15.53
Dividend yield:
0%
P/E ratio:
24.87x
P/S ratio:
--
P/B ratio:
2.10x
Volume:
54.4K
Avg. volume:
420.1K
1-year change:
-44.5%
Market cap:
$10.8B
Revenue:
$40.8M
EPS (TTM):
$0.32
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $40.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $44.7M | -- | -- | -- | $51.6M | |
| Gross Profit | -$44.7M | -- | -- | -- | -$10.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -26.32% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $33M | $39.5M | $41.4M | $63.5M | $66.7M | |
| Other Inc / (Exp) | -$27.3M | $7.7M | $275.4M | $175.2M | $115.8M | |
| Operating Expenses | $45.1M | $106.8M | $91.9M | $88M | $118.4M | |
| Operating Income | -$89.9M | -$106.8M | -$91.9M | -$88M | -$129.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$38.1M | -$29.6M | $320.7M | $295.3M | $179.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $500K | -$74.9M | -$113.4M | -$7.7M | -$14.2M | |
| Net Income to Company | -$38.1M | -$29.6M | $320.7M | $295.3M | $179.1M | |
| Minority Interest in Earnings | $18.7M | $9.9M | -$23.2M | $16M | $34.8M | |
| Net Income to Common Excl Extra Items | -$19.9M | $55.2M | $410.9M | $318.9M | $228.1M | |
| Basic EPS (Cont. Ops) | -$0.02 | $0.05 | $0.34 | $0.26 | $0.17 | |
| Diluted EPS (Cont. Ops) | -$0.02 | $0.05 | $0.33 | $0.26 | $0.17 | |
| Weighted Average Basic Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.3B | |
| Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.2B | $1.3B | |
| EBITDA | -$28M | $12.9M | $343.9M | $289.5M | $208.1M | |
| EBIT | -$36.4M | $3.3M | $338M | $287.2M | $188.4M | |
| Revenue (Reported) | -- | -- | -- | -- | $40.8M | |
| Operating Income (Reported) | -$89.9M | -$106.8M | -$91.9M | -$88M | -$129.1M | |
| Operating Income (Adjusted) | -$36.4M | $3.3M | $338M | $287.2M | $188.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $77M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8.7M | -- | -- | -- | $81.8M | |
| Gross Profit | -$8.7M | -- | -- | -- | -$4.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -6.17% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6M | $10.4M | $10.4M | $15.6M | $10.9M | |
| Other Inc / (Exp) | $18.4M | $25.2M | $51.7M | -$101.6M | $109.3M | |
| Operating Expenses | $10.2M | $26.5M | $17.4M | $24.5M | $20.1M | |
| Operating Income | -$18.9M | -$26.5M | -$17.4M | -$24.5M | -$24.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $20.5M | $22.7M | $81.6M | -$72.6M | $118.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $63K | $1.2M | -$881K | -$3.2M | -$4M | |
| Net Income to Company | $20.5M | $22.7M | $81.6M | -$72.6M | $118.2M | |
| Minority Interest in Earnings | $3.6M | $4.9M | $4.2M | $3.9M | $7.6M | |
| Net Income to Common Excl Extra Items | $24.1M | $26.4M | $86.6M | -$65.6M | $129.8M | |
| Basic EPS (Cont. Ops) | $0.02 | $0.02 | $0.07 | -$0.05 | $0.10 | |
| Diluted EPS (Cont. Ops) | $0.02 | $0.02 | $0.07 | -$0.05 | $0.10 | |
| Weighted Average Basic Share | $1.2B | $1.2B | $1.2B | $1.3B | $1.4B | |
| Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.3B | $1.4B | |
| EBITDA | $24.6M | $32.6M | $92.5M | -$62.9M | $140.5M | |
| EBIT | $22.3M | $30.1M | $92.1M | -$63.6M | $126.1M | |
| Revenue (Reported) | -- | -- | -- | -- | $77M | |
| Operating Income (Reported) | -$18.9M | -$26.5M | -$17.4M | -$24.5M | -$24.8M | |
| Operating Income (Adjusted) | $22.3M | $30.1M | $92.1M | -$63.6M | $126.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $41.5M | -- | -- | -- | -- | |
| Gross Profit | -$41.5M | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $28.8M | $44M | $41.4M | $68.6M | $66.3M | |
| Other Inc / (Exp) | $863K | $14.3M | $301.9M | $23.2M | $326.7M | |
| Operating Expenses | $41.9M | $122.9M | $95M | $96.3M | $113.9M | |
| Operating Income | -$83.4M | -$114.2M | -$82.8M | -$96.3M | -$129.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$3.2M | -$27.3M | $379.6M | $141.1M | $369.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $890K | -$73.8M | -$115.5M | -$9.9M | -$15M | |
| Net Income to Company | -$3.2M | -$27.3M | $379.6M | $141.1M | $369.9M | |
| Minority Interest in Earnings | $17.4M | $11.1M | -$23.9M | $15.7M | $38.5M | |
| Net Income to Common Excl Extra Items | $13.4M | $57.6M | $471.1M | $166.7M | $423.4M | |
| Basic EPS (Cont. Ops) | $0.01 | $0.04 | $0.39 | $0.14 | $0.32 | |
| Diluted EPS (Cont. Ops) | $0.01 | $0.04 | $0.24 | $0.12 | $0.32 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $7.9M | $20.8M | $403.8M | $134.1M | $411.5M | |
| EBIT | $197K | $11.1M | $400M | $131.5M | $378.2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$83.4M | -$114.2M | -$82.8M | -$96.3M | -$129.4M | |
| Operating Income (Adjusted) | $197K | $11.1M | $400M | $131.5M | $378.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $77M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8.7M | -- | -- | -- | $81.8M | |
| Gross Profit | -$8.7M | -- | -- | -- | -$4.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6M | $10.4M | $10.4M | $15.6M | $10.9M | |
| Other Inc / (Exp) | $18.4M | $25.2M | $51.7M | -$101.6M | $109.3M | |
| Operating Expenses | $10.2M | $26.5M | $17.4M | $24.5M | $20.1M | |
| Operating Income | -$18.9M | -$26.5M | -$17.4M | -$24.5M | -$24.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $20.5M | $22.7M | $81.6M | -$72.6M | $118.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $63K | $1.2M | -$881K | -$3.2M | -$4M | |
| Net Income to Company | $20.5M | $22.7M | $81.6M | -$72.6M | $118.2M | |
| Minority Interest in Earnings | $3.6M | $4.9M | $4.2M | $3.9M | $7.6M | |
| Net Income to Common Excl Extra Items | $24.1M | $26.4M | $86.6M | -$65.6M | $129.8M | |
| Basic EPS (Cont. Ops) | $0.02 | $0.02 | $0.07 | -$0.05 | $0.10 | |
| Diluted EPS (Cont. Ops) | $0.02 | $0.02 | $0.07 | -$0.05 | $0.10 | |
| Weighted Average Basic Share | $1.2B | $1.2B | $1.2B | $1.3B | $1.4B | |
| Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.3B | $1.4B | |
| EBITDA | $24.6M | $32.6M | $92.5M | -$62.9M | $140.5M | |
| EBIT | $22.3M | $30.1M | $92.1M | -$63.6M | $126.1M | |
| Revenue (Reported) | -- | -- | -- | -- | $77M | |
| Operating Income (Reported) | -$18.9M | -$26.5M | -$17.4M | -$24.5M | -$24.8M | |
| Operating Income (Adjusted) | $22.3M | $30.1M | $92.1M | -$63.6M | $126.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $262.8M | $608.2M | $597.5M | $560.3M | $102.1M | |
| Short Term Investments | $300K | -- | -- | -- | -- | |
| Accounts Receivable, Net | $513K | $1.4M | -- | -- | -- | |
| Inventory | $1M | $995K | $1M | $1.5M | $85.7M | |
| Prepaid Expenses | $3.9M | $4.9M | $28.5M | $50M | $19M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $331M | $686.7M | $662.7M | $648.8M | $298.6M | |
| Property Plant And Equipment | $725.1M | $742.3M | $902.8M | $1.4B | $2B | |
| Long-Term Investments | $1.3B | $1.6B | $2.1B | $2.6B | $3.1B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | $3.9M | $4.4M | $4.2M | $18.9M | |
| Total Assets | $2.4B | $3.2B | $4B | $5B | $5.7B | |
| Accounts Payable | $17.2M | $22.8M | $61.6M | $96.9M | $118.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $3M | $686.6M | $886.2M | $97.5M | |
| Current Portion Of Capital Lease Obligations | $350K | $729K | $546K | $675K | $725K | |
| Other Current Liabilities | -- | $1.4M | $2M | $1.5M | $1.8M | |
| Total Current Liabilities | $23M | $32M | $750.8M | $997.3M | $238.6M | |
| Long-Term Debt | $39M | $475.6M | $43.9M | $56.3M | $261M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $80.6M | $841.2M | $1.1B | $1.4B | $901.9M | |
| Common Stock | $2.3B | $2.3B | $2.3B | $2.8B | $3.9B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $2.4B | $2.5B | $2.9B | $3.7B | $5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$104.2M | -$116.8M | -$93.5M | -$117.5M | -$153.6M | |
| Total Equity | $2.3B | $2.4B | $2.8B | $3.6B | $4.8B | |
| Total Liabilities and Equity | $2.4B | $3.2B | $4B | $5B | $5.7B | |
| Cash and Short Terms | $263.1M | $608.2M | $597.5M | $560.3M | $102.1M | |
| Total Debt | -- | -- | -- | -- | $358.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $731.9M | $562M | $484M | $397.1M | $701.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.2M | $4.1M | -- | -- | -- | |
| Inventory | $995K | $986K | $937K | $3.2M | $83.1M | |
| Prepaid Expenses | $3.6M | $6.1M | $35M | $36.6M | $24.2M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $800.7M | $644.1M | $568.5M | $479.1M | $913.5M | |
| Property Plant And Equipment | $725.4M | $796.7M | $952.5M | $1.5B | $2B | |
| Long-Term Investments | $1.4B | $1.8B | $2.2B | $2.7B | $3.3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | $10.1M | -- | |
| Other Long-Term Assets | -- | $4.7M | $4.5M | $4.9M | $39.5M | |
| Total Assets | $3B | $3.4B | $4.1B | $5.1B | $6.6B | |
| Accounts Payable | $14.6M | $16M | $42.8M | $89.6M | $98.3M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $6.6M | $6.6M | $1B | $122.6M | |
| Current Portion Of Capital Lease Obligations | $333K | $804K | $564K | $675K | $742K | |
| Other Current Liabilities | -- | $870K | $2.3M | $1.8M | $1.1M | |
| Total Current Liabilities | $18.9M | $28.7M | $54.8M | $1.1B | $236.7M | |
| Long-Term Debt | $452.5M | $482.8M | $514.2M | $56.6M | $977.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $617.8M | $922M | $1.1B | $1.6B | $1.6B | |
| Common Stock | $2.3B | $2.3B | $2.4B | $2.8B | $3.9B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$108.3M | -$119.7M | -$98.9M | -$122.3M | -$160.7M | |
| Total Equity | $2.4B | $2.4B | $2.9B | $3.5B | $5B | |
| Total Liabilities and Equity | $3B | $3.4B | $4.1B | $5.1B | $6.6B | |
| Cash and Short Terms | $731.9M | $562M | $484M | $397.1M | $701.1M | |
| Total Debt | -- | -- | -- | -- | $1.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$38.1M | -$29.6M | $320.7M | $295.3M | $179.1M | |
| Depreciation & Amoritzation | $8.4M | $9.6M | $5.9M | $2.3M | $19.7M | |
| Stock-Based Compensation | $15.4M | $20M | $27.2M | $29.3M | $27.9M | |
| Change in Accounts Receivable | $1.6M | -$4.3M | -$5M | -$16.8M | -$48.4M | |
| Change in Inventories | $43K | $22K | -$16K | -$510K | -$76.2M | |
| Cash From Operations | -$60.5M | -$7.1M | $177M | -$31.6M | -$152.4M | |
| Capital Expenditures | -- | -- | -- | -- | $491.7M | |
| Cash Acquisitions | -$6.7M | -$3.2M | -$39K | -$44K | $749K | |
| Cash From Investing | -$380.3M | -$208.6M | -$173.6M | -$477M | -$495.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $564.5M | -- | $98.2M | $306M | |
| Long-Term Debt Repaid | -$863K | -$716K | -$714K | -$1.8M | -$85.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$297K | -- | -- | -$16.5M | -$6.6M | |
| Cash From Financing | $1.1M | $562M | -$9.6M | $500.3M | $206.9M | |
| Beginning Cash (CF) | $702.8M | $262.8M | $608.2M | $597.5M | $574.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$439.6M | $346.3M | -$6.2M | -$8.3M | -$440.9M | |
| Ending Cash (CF) | $262.8M | $608.2M | $597.5M | $574.3M | $117.3M | |
| Levered Free Cash Flow | -$102.5M | -$59.7M | $18.3M | -$509.5M | -$644.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $20.5M | $22.7M | $81.6M | -$72.6M | $118.2M | |
| Depreciation & Amoritzation | $2.4M | $2.5M | $477K | $758K | $14.4M | |
| Stock-Based Compensation | $3.1M | $7.4M | $7.7M | $8.9M | $2.4M | |
| Change in Accounts Receivable | -$57K | -$713K | $477K | -$9.6M | -$14.4M | |
| Change in Inventories | $22K | $9K | $74K | -$1.7M | $2.7M | |
| Cash From Operations | -$20.2M | -$23.8M | -$24.2M | -$17.8M | -$55.1M | |
| Capital Expenditures | -- | -- | -- | -- | $70.8M | |
| Cash Acquisitions | -$1.4M | -- | -$10K | -- | -$1K | |
| Cash From Investing | -$78.1M | -$33.3M | -$65.4M | -$139.4M | -$75.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $564.7M | -- | -- | -- | $750M | |
| Long-Term Debt Repaid | -$182K | -$547K | -$70K | -$1.1M | -$2.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$20.7M | |
| Cash From Financing | $567.1M | $2.2M | $965K | $536K | $726.5M | |
| Beginning Cash (CF) | $262.8M | $608.2M | $597.5M | $574.3M | $117.3M | |
| Foreign Exchange Rate Adjustment | $286K | $8.7M | -$11.7M | -$6.5M | $3.5M | |
| Additions / Reductions | $468.8M | -$54.8M | -$88.6M | -$156.7M | $596.2M | |
| Ending Cash (CF) | $731.9M | $562M | $497.1M | $411.1M | $717M | |
| Levered Free Cash Flow | -$26.8M | -$43M | -$94M | -$156.6M | -$125.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.2M | -$27.3M | $379.6M | $141.1M | $369.9M | |
| Depreciation & Amoritzation | $7.7M | $9.7M | $3.9M | $2.6M | $33.3M | |
| Stock-Based Compensation | $14.7M | $24.2M | $27.5M | $30.5M | $21.4M | |
| Change in Accounts Receivable | -$594K | -$4.9M | -$3.9M | -$26.8M | -$53.2M | |
| Change in Inventories | $34K | $9K | $49K | -$2.3M | -$71.8M | |
| Cash From Operations | -$62.3M | -$10.7M | $176.5M | -$25.2M | -$189.7M | |
| Capital Expenditures | -- | -- | -- | -- | $167.1M | |
| Cash Acquisitions | -$6.9M | -$1.8M | -$49K | -$34K | $748K | |
| Cash From Investing | -$383.4M | -$163.8M | -$205.8M | -$551M | -$431.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $98.2M | $1.1B | |
| Long-Term Debt Repaid | -$945K | -$1.1M | -$237K | -$2.8M | -$87.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $568.2M | -$3M | -$10.8M | $499.8M | $932.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $122.5M | -$177.4M | -$40M | -$76.3M | $312M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$100.2M | -$75.8M | -$32.7M | -$572.1M | -$613.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $20.5M | $22.7M | $81.6M | -$72.6M | $118.2M | |
| Depreciation & Amoritzation | $2.4M | $2.5M | $477K | $758K | $14.4M | |
| Stock-Based Compensation | $3.1M | $7.4M | $7.7M | $8.9M | $2.4M | |
| Change in Accounts Receivable | -$57K | -$713K | $477K | -$9.6M | -$14.4M | |
| Change in Inventories | $22K | $9K | $74K | -$1.7M | $2.7M | |
| Cash From Operations | -$20.2M | -$23.8M | -$24.2M | -$17.8M | -$55.1M | |
| Capital Expenditures | -- | -- | -- | -- | $70.8M | |
| Cash Acquisitions | -$1.4M | -- | -$10K | -- | -$1K | |
| Cash From Investing | -$78.1M | -$33.3M | -$65.4M | -$139.4M | -$75.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $564.7M | -- | -- | -- | $750M | |
| Long-Term Debt Repaid | -$182K | -$547K | -$70K | -$1.1M | -$2.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$20.7M | |
| Cash From Financing | $567.1M | $2.2M | $965K | $536K | $726.5M | |
| Beginning Cash (CF) | $262.8M | $608.2M | $597.5M | $574.3M | $117.3M | |
| Foreign Exchange Rate Adjustment | $286K | $8.7M | -$11.7M | -$6.5M | $3.5M | |
| Additions / Reductions | $468.8M | -$54.8M | -$88.6M | -$156.7M | $596.2M | |
| Ending Cash (CF) | $731.9M | $562M | $497.1M | $411.1M | $717M | |
| Levered Free Cash Flow | -$26.8M | -$43M | -$94M | -$156.6M | -$125.8M | |
Get IVPAF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IVPAF
Sector
P/E ratio
24.87x
16.29x
PEG ratio
--
0.00x
P/B ratio
2.10x
1.42x
Price / LTM sales
--
1.42x
Growth Metrics
IVPAF
Sector
Revenue growth
--
1.07%
Earnings growth
250%
--
Revenue (5-year growth)
--
3.71%
Earnings forecast
$0.04
$0.04
Profitability
IVPAF
Sector
Profitability FY 2024
-$10.7M
--
Return on invested capital
--
1.75%
Return on assets
--
1.06%
Return on equity
--
2.52%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Jul
30
Balance Sheet
IVPAF
Sector
Total cash
$701.1M
$2.4M
Short term investments
--
$326.7K
Total assets
$5.7B
$21.1M
Long term debt
$1.1B
$74M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
